Nicole Ward explores groundbreaking psoriatic disease research methods published in recent literature. Discover how Spatial Transcriptomics and Single Cell Sequencing
Explore the results of a randomized controlled trial on the efficacy and safety of oral roflumilast for moderate to severe
A host of factors is important to consider in the personalized treatment of psoriasis. It is advantageous if a treatment
The 2023 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 16 – Tuesday, March 21, 2023, in
The prognosis and maintenance of response after treatment discontinuation following remission lack proper characterization. Real-world data obtained from national registries
Dr. Gudjonsson highlights disease memory and how it can provide a potential treatment target.
Dr. Blauvelt discusses results from his research study where high doses of a medication is provided to “knock out” disease
Dr. Smith reviews how biomarkers can be used to identify patients at risk for severe disease and those who would
Recently, a study was conducted on the effect of apremilast on vascular inflammation and cardiometabolic functions with an impressively comprehensive
The United States Food and Drug Administration (FDA) has approved deucravacitinib to treat psoriasis. Recently, 52-week efficacy and safety data
